MAC 800 RESTING ECG ANALYSIS SYSTEM
K090212 · Ge Medical Syst. Information Technologies · DPS · Feb 19, 2009 · Cardiovascular
Device Facts
| Record ID | K090212 |
| Device Name | MAC 800 RESTING ECG ANALYSIS SYSTEM |
| Applicant | Ge Medical Syst. Information Technologies |
| Product Code | DPS · Cardiovascular |
| Decision Date | Feb 19, 2009 |
| Decision | SESE |
| Submission Type | Special |
| Regulation | 21 CFR 870.2340 |
| Device Class | Class 2 |
| Attributes | Pediatric |
Intended Use
The MAC 800 is a portable ECG acquisition, analysis and recording system. The MAC 800 is intended to acquire, analyze, display and record information from adult and pediatric populations. Pediatric population is defined as patients between the ages of 0 and 15 years. The MAC 800 is intended to be used by trained operators in a hospital or medical professional's facility environment to record ECG signals from surface electrodes. The basic system shall provide 2 modes of operation: (1) Resting ECG mode and (2) Arrhythmia mode. The basic systems shall print 3, 6-leads of ECG. The device shall be upgradeable to provide software options such as 12-lead ECG measurement and interpretive analysis. Transmission and reception of ECG data to and from a central ECG cardiovascular information system shall be optional. The arrhythmia detection portion of the MAC 800 is provided to the customer for the convenience of automatic documentation. The MAC 800 is used under the direct supervision of a licensed healthcare practitioner.
Device Story
Portable ECG acquisition, analysis, and recording system; inputs ECG signals via surface electrodes. Features integrated 7" display, thermal writer, and keypad for data entry. Operates in Resting ECG or Arrhythmia modes; provides real-time waveform printing and optional 12-lead measurement/interpretation. Used in hospitals/clinics by trained operators; supports optional data transmission to central cardiovascular information systems. Output includes printed reports, PDF files on SD cards, or digital records. Assists clinicians in diagnostic documentation; arrhythmia detection provided for convenience only, not as a clinical alarm system.
Clinical Evidence
No clinical data; bench testing only. System verification and validation included module-level testing, integration testing, and performance/safety testing to confirm substantial equivalence.
Technological Characteristics
Portable ECG system with integrated thermal writer, 7" color display, and keypad. Supports 3, 6, and optional 12-lead ECG acquisition. Connectivity includes optional SD card storage, barcode/magnetic card scanners, and network transmission to central information systems. Software includes optional measurement and interpretive analysis modules. Operates on AC/battery power.
Indications for Use
Indicated for adult and pediatric (0-15 years) patients for ECG acquisition, analysis, display, and recording. Used by trained operators in hospitals or medical facilities under licensed practitioner supervision. Contraindicated for intra-cardiac use, as a vital signs monitor, or during patient transport.
Regulatory Classification
Identification
An electrocardiograph is a device used to process the electrical signal transmitted through two or more electrocardiograph electrodes and to produce a visual display of the electrical signal produced by the heart.
Predicate Devices
- MAC 1600 ECG Analysis System (K081437)
Related Devices
- K142288 — MAC 800 Resting ECG Analysis System · Ge Medical Systems China Co., Ltd. · Dec 3, 2014
- K081437 — MAC 1600 ECG ANALYSIS SYSTEM · Ge Medical Systems Information Technologies · Jul 15, 2008
- K133622 — MAC 2000 ECG ANALYSIS SYSTEM · Wipro GE Healthcare · Jan 23, 2014
- K981066 — FUKUDA DENSHI: CARDIOMAX, MODEL FX-4010 MULTI CHANNEL ELECTROCARDIOGRAPH · Fukuda Denshi USA, Inc. · Aug 31, 1998
- K173830 — MAC VU360 Resting ECG Analysis System · Ge Medical Systems Information Technologies, Inc. · Sep 18, 2018
Submission Summary (Full Text)
{0}------------------------------------------------
090212
# GE Healthcare 510(K) Premarket Notification Submission MAC 800 Resting ECG Analysis System
## 510(k) Summary
In accordance with 21 CFR 807.92 the following summary of information is provided:
| Date: | January 26, 2009 | | |
|---------------------------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|---------------------------------------------------------------|------|
| Submitter: | Larry Lepley<br>Regulatory Affairs - Diagnostic Cardiology<br>9900 Innovation Drive<br>Wauwatosa, WI 53226 | | |
| Primary Contact Person: | Larry Lepley<br>Regulatory Affairs - Diagnostic Cardiology<br>9900 Innovation Drive<br>Wauwatosa, WI 53226<br>T: (414) 721-2593<br>F: (414) 721-3899 | | |
| Secondary Contact Person: | Patricia Taige<br>Regulatory Affairs - Diagnostic Cardiology<br>9900 Innovation Drive<br>Wauwatosa, WI 53226<br>T: (414) 721-3222<br>F: (414) 721-3899 | | |
| Device: Trade Name: | MAC 800 Resting ECG Analysis System | | |
| Common/Usual Name: | Electrocardiograph | | |
| Classification Names: | 21 CFR | Classification Name | Code |
| Product Code: | 870.2340 | Electrocardiograph | DPS |
| | 870.1425 | Programmable Diagnostic Computer | DQK |
| | 870.2920 | Transmitters and Receivers,<br>Electrocardiographs, Telephone | DXH |
| Predicate Device(s): | K081437, MAC 1600 ECG Analysis System | | |
| Device Description: | The MAC 800 ECG acquisition, analysis and recording system<br>can print and display multiple leads of ECG data. The MAC 800<br>will provide, in resting ECG mode, ECG quality information<br>using the hookup advisor. The hookup advisor advises users of<br>poor lead quality based on noise measurement. It can be upgraded<br>to provide options such as ECG measurement and interpretation<br>with 12SL. Transmission and reception of ECG data to and from<br>a central ECG cardiovascular information system is also optional.<br>Multiple QT correction formulas including Bazett, Framingham<br>and Fridericia will be available as a user selectable option.<br>Clinical Trials Data Guard and audit trail options are also | | |
FR Page 1 OF 3
{1}------------------------------------------------
## GE Healthcare 510(K) Premarket Notification Submission MAC 800 Resting ECG Analysis System
The MAC 800 delivers multiple leads of ECG on full-size reports and includes an SMS/text message telephone keypad for patient demographics and other data entry with T9 input method, an integrated 7" color display, and an integrated thermal writer. The thermal writer will print real time continuous waveform, alphanumeric data and non real time reports. The device can print the resting ECG report via the external laser printer. The device will have optional internal memory and removable storage to store resting ECG records. The device also can export the resting ECG record to PDF file on SD card as an optional function. An optional barcode reader and magnetic card scanner to enter patient information is available. The MAC 800 can be used as a portable unit.
The MAC 800 is a portable ECG acquisition, analysis and recording Intended Use: system.
> The MAC 800 is intended to acquire, analyze, display and record information from adult and pediatric populations. Pediatric population is defined as patients between the ages of 0 and 15 years.
> The MAC 800 is intended to be used by trained operators in a hospital or medical professional's facility environment to record ECG signals from surface electrodes.
The basic system shall provide 2 modes of operation: (1) Resting ECG mode and (2) Arrhythmia mode.
The basic systems shall print 3, 6-leads of ECG. The device shall be upgradeable to provide software options such as 12-lead ECG measurement and interpretive analysis.
Transmission and reception of ECG data to and from a central ECG cardiovascular information system shall be optional.
The arrhythmia detection portion of the MAC 800 is provided to the customer for the convenience of automatic documentation.
The MAC 800 is used under the direct supervision of a licensed healthcare practitioner.
Contraindications:
The MAC 800 is not designed to provide alarms for arrhythmia detection.
The device is not suitable for intra cardiac application.
It is not intended for use:
- · As a vital signs physiological monitor; or
- For use during patient transport.
E Page 2 of 3
{2}------------------------------------------------
# GE Healthcare
## 510(K) Premarket Notification Submission MAC 800 Resting ECG Analysis System
## Technology:
The MAC 800 Resting ECG Analysis System employs the same functional scientific technology as its predicate devices.
#### Determination of Summary of Non-Clinical Tests:
Substantial Equivalence: The MAC 800 Resting ECG Analysis System and its applications comply with voluntary standards as detailed in Section 9, 11 and 17 of this premarket submission. The following quality assurance
measures were applied to the development of the system:
- Risk Analysis .
- Requirements Reviews .
- Design Reviews
- Testing on unit level (Module verification)
- Integration testing (System verification)
- Final acceptance testing (Validation)
- Performance testing (Verification)
- Safety testing (Verification)
#### Summary of Clinical Tests:
The subject of this premarket submission, MAC 800 Resting ECG Analysis System, did not require clinical studies to support substantial equivalence.
Conclusion:
GE Healthcare considers the MAC 800 Resting ECG Analysis System to be as safe, as effective, and performance is substantially equivalent to the predicate device.
傍
{3}------------------------------------------------
#### DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal features an eagle-like symbol with three stylized lines forming its body and wings. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the emblem.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
# FEB 1 9 2009
GE Medical Systems Information Technologies c/o Mr. Larry Lepley Regulatory Affairs - Diagnostic Cardiology 9900 Innovation Drive Wauwatosa, WI 53226
Re: K090212 -
Trade Name: MAC 800 Resting ECG Analysis System Regulation Number: 21 CFR 870.2340 Regulation Name: Electrocardiograph Regulatory Class: Class II Product Code: DPS and DQK Dated: January 26, 2009 Received: January 28, 2009
#### Dear Mr. Lepley:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controll provisions plathe Age melude requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
{4}------------------------------------------------
### Page 2 - Mr. Larry Lepley
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Center for Devices and Radiological Health's (CDRH's) Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notifications" (21CFR Part 807.97) For questions regarding posimarket surveillance, please contact CDRH s Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at 240-276-3474. For questions regarding the reporting of device adverse events (Medical Device Reporting (MDR)), please contact the Division of Surveillance Systems at 240-276-3464. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
87 Bram D. Zuckerman, M.D. Director Division of Cardiovascular Devices Office of Device Evaluation Center for I levices and Radiological Health
Enclosure
{5}------------------------------------------------
# GE Healthcare
510(K) Premarket Notification Submission MAC 800 Resting ECG Analysis System
510(k) Number (if known)
510(k) Number (if known): `K090312
Device Name:
MAC 800 Resting ECG Analysis System
Indications for Use:
The MAC 800 is a portable ECG acquisition, analysis and recording system. The MAC 800 is intended to acquire, analyze, display and record information from adult and pediatric populations. Pediatric population is defined as patients between the ages of 0 and 15 years.
The MAC 800 is intended to be used by trained operators in a hospital or medical professional's facility environment to record ECG signals from surface electrodes.
The basic system shall provide 2 modes of operation: {1} Resting ECG mode and (2) Arrhythmia mode.
The basic systems shall print 3, 6-leads of ECG. The device shall be upgradeable to provide software options such as 12-lead ECG measurement and interpretive analysis.
Transmission and reception of ECG data to and from a central ECG cardiovascular information system shall be optional.
The arrhythmia detection portion of the MAC 800 is provided to the customer for the convenience of automatic documentation.
The MAC 800 is used under the direct supervision of a licensed healthcare practitioner.
#### Contraindications:
The MAC 800 is not designed to provide alarms for arrhythmia detection. The device is not suitable for intra cardiac application. It is not intended for use:
· As a vital signs physiological monitor; or
For use during patient transport.
Prescription Use X AND/OR .. Over-The-Counter Use (Port 21 CFR 801 Submart D) (Part 21:CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
(Division Sign-Off) for Zuckerman
2/20/09
Division of Cardiovascular Devices
510(k) Number K090212
ાર